Printer Friendly

MEDCO RESEARCH FILES COMPLAINT AGAINST FUJISAWA PHARMACEUTICAL CO.

 LOS ANGELES, May 6 /PRNewswire/ -- Medco Research, Inc. (AMEX: MRE) said today it filed a complaint in the United States District Court, Northern District of Illinois, seeking $145 million in damages, plus $200 million in punitive damages, from Fujisawa Pharmaceutical Co. Ltd. and Fujisawa USA, Inc.
 Medco's complaint charges Fujisawa with, among other things, breach of contract, fraud, breach of fiduciary duty, breach of good faith and fair dealing, and negligent misrepresentation in connection with the company's Development and License Agreement with Fujisawa for Medco's Adenoscan product. Under that agreement, Medco had granted Fujisawa the exclusive right to manufacture, market and sell Adenoscan in the United States and Canada. Medco terminated the agreement, effective May 4, after several months of unsuccessful negotiations attempting to resolve its differences with Fujisawa.
 Adenoscan is being developed as a pharmacologic alternative to exercise stress testing for the detection of coronary disease.
 Medco Research is a pharmaceutical company engaged in the acquisition, research and development of new prescription drugs for the diagnosis or treatment of certain cardiovascular diseases and cancer.
 -0- 5/6/93
 /CONTACT: Archie W. Prestayko, Ph.D. of Medco Research, 213-966-4148, or Fredric J. Spar of Kekst and Company, 212-593-2655, for Medco Research/
 (MRE)


CO: Medco Research, Inc.; Fujisawa Pharmaceutical Co. Ltd. ST: California, Illinois IN: MTC SU:

PS -- NY018 -- 5222 05/06/93 08:43 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 6, 1993
Words:225
Previous Article:SAM & LIBBY REPORTS FIRST QUARTER RESULTS
Next Article:AMES REPORTS APRIL SALES
Topics:


Related Articles
FUJISAWA USA. INC. FILES DECLARATION JUDGEMENT ACTION AGAINST MEDCO RESEARCH INC.
MEDCO'S FRAUD CLAIMS AGAINST FUJISAWA UPHELD BY COURT
FUJISAWA USA PREPARES FOR ADENOSCAN(R) APPROVAL, PURSUES COMPLAINT AGAINST MEDCO RESEARCH AND ABBOTT
FUJISAWA QUALIFIES TO MANUFACTURE ADENOSCAN
MEDCO RESEARCH CLASS ACTION LAWSUITS DISMISSED BY COURT
MEDCO ANNOUNCES ADENOSCAN NEARING FINAL APPROVAL, COURT ISSUES PRELIMINARY INJUNCTION
MEDCO RESEARCH AND FUJISAWA USA SETTLE LAWSUITS OVER ADENOSCAN
JUDGE RULES ON TECHNICALITY IN FUJISAWA USA, INC. SUIT; STATE CAUSE OF ACTION STILL OPEN
Kapoor Files Lawsuit Against Fujisawa
Fujisawa USA Informs Medco Research of Adenoscan(R) Patent Infringement Lawsuit By Third Party

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters